MEHLMAN CONSULTING, INC.

Lobbying for THE ERISA INDUSTRY COMMITTEE · Trade Association

Filing 1st Quarter - Termination

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Mar 17, 2025

Lobbying activity 1

Issues related to pharmaceutical patents.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem